Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

2(50.0%)

Phase 4

1(25.0%)

N/A

1(25.0%)

4Total

Phase 1(2)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05309408Unknown

A Longitudinal Analysis of Biomarkers in Patients With ALS

Role: lead

NCT03883581Phase 1Completed

Impact of Nuedexta on Bulbar Physiology and Function in ALS

Role: collaborator

NCT02493205Completed

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

Role: lead

NCT04093440Not ApplicableUnknown

Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes

Role: lead

NCT01090830Phase 1Terminated

Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer

Role: lead

NCT02765815Phase 4Withdrawn

A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients

Role: lead

NCT02948049Terminated

Accelerometer Based Objective Clinical Outcomes of Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS)

Role: lead

All 7 trials loaded